Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
influenza
|
| gptkbp:adjuvantType |
oil-in-water emulsion
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration 1997 |
| gptkbp:ATCCode |
J07BB02
|
| gptkbp:brand |
gptkb:Fluad
|
| gptkbp:contains |
gptkb:MF59_adjuvant
inactivated influenza virus |
| gptkbp:contraindication |
severe allergic reaction to any component
|
| gptkbp:countryOfOperation |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:form |
quadrivalent
trivalent 0.5 mL per dose |
| https://www.w3.org/2000/01/rdf-schema#label |
Fluad vaccine
|
| gptkbp:indication |
prevention of influenza
|
| gptkbp:manufacturer |
gptkb:Seqirus
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fatigue
headache injection site pain myalgia |
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:targetAudience |
adults aged 65 years and older
|
| gptkbp:bfsParent |
gptkb:MF59_adjuvant
|
| gptkbp:bfsLayer |
7
|